The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance
Ariel Ka-Man Chow(Metropolitan University), Roberta Wen-Chi Pang(University of Hong Kong)
Cited by 124
Related Papers
Lower Risks of New-Onset Hepatocellular Carcinoma in Patients With Type 2 Diabetes Mellitus Treated With SGLT2 Inhibitors Versus DPP4 Inhibitors
|Journal of the National Comprehensive Cancer Network|2024|24